先看重點
在205名英國失眠且有憂鬱症狀的成年人試驗中,數字化CBT-I在10週時並未改變對快樂面孔(3.01,P = .15)和悲傷面孔(-0.54,P = .72)的識別準確率,但與睡眠衛生教育相比降低了失眠(-4.27)和憂鬱症狀(-3.91)。參與者透過網路招募,女性佔80.8%,中介分析屬探索性。
證據類型
隨機對照試驗
解讀依據
公開摘要
閱讀重點
對照與不確定性
研究在問什麼
失眠認知行為療法(CBT-I)能減輕憂鬱症狀,但其作用機制並不清楚。作者檢驗了它是否會減少對情緒面孔的負性偏向,以及這種變化是否能解釋情緒的改善。
研究對象與方法
隨機臨床試驗,物件為符合失眠障礙診斷標準且患者健康問卷-9得分達到10分及以上的英國成年人,於2021年4月26日至2022年1月24日透過網路招募。205名參與者被隨機分配到6次課程的數字化CBT-I專案(101人)或睡眠衛生網頁(104人),並在5週和10週時評估。共同主要結局為10週時對快樂和悲傷面孔表情的識別準確率;次要結局包括失眠、憂鬱症狀、情緒、情緒調節、擔憂、持續性思維、睡眠中點和社交時差。採用意向性治療分析。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1平均年齡49.3歲(標準差10.1);165人(80.8%)為女性;保留率85.7%(175人)。
- 2共同主要結局在10週時無顯著差異:快樂面孔3.01(97.5%置信區間-1.67至7.69;P = .15;Cohen d = 0.24),悲傷面孔-0.54(97.5%置信區間-3.92至2.84;P = .72;Cohen d = -0.05)。
- 3與睡眠衛生教育相比,CBT-I降低了失眠嚴重程度(校正差值-4.27,95%置信區間-5.67至-2.87)、憂鬱症狀(-3.91,-5.20至-2.62)、負性情緒(-2.75)、情緒調節困難(-5.96)、擔憂(-8.07)和持續性思維(-4.21),並提高了正性情緒(4.99)。
- 4第5週時負性情緒(中介比例29.7%)、擔憂(24.4%)和情緒調節困難(21.9%)的早期改善,介導了10週時對憂鬱的效果。向試驗團隊報告的嚴重不良事件為零。
限制與不確定性
- 1參與者透過網路招募且以女性為主,且有一定失訪(保留率85.7%),結果未必適用於其他族群。
- 2對照組只是一個睡眠衛生網頁,屬於較弱的對照,差異部分來自與極簡介入的對比,追蹤也僅到10週。
- 3對次要指標的中介分析不能證明擔憂或情緒變化導致了憂鬱改善;面孔識別測試可能不夠敏感,97.5%置信區間也較寬。本解讀僅基於摘要。
日常健康啟示
對同時有失眠和憂鬱症狀的人,數字化CBT-I在10週內改善了睡眠和憂鬱,獲益似乎部分透過減少擔憂和負面情緒實現,而不是透過改變對面孔的解讀。若失眠或情緒低落持續,請與醫師討論治療選擇。
如何連結自己的資料
CBT-I的效果通常用睡眠日記和問卷評估,手錶記錄的睡眠時長和就寢規律性可作補充。穿戴式裝置的睡眠分期只是估算,請重點關注固定的睡眠與起床時間,以及自己睡眠時長的每週趨勢。
如何理解這類證據
隨機分組有助於因果推斷,仍須檢查分配、盲法、失去追蹤、追蹤時間和具體對照;標為隨機試驗不自動意味著高確定性。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Importance
Cognitive behavioral therapy for insomnia (CBT-I) has been shown to reduce depressive symptoms, but the underlying mechanisms are not well understood and warrant further examination.
Objective
To investigate whether CBT-I modifies negative bias in the perception of emotional facial expressions and whether such changes mediate improvement in depressive symptoms.
Design, setting, and participants
A randomized clinical trial of digital CBT-I vs sleep hygiene education was conducted. Adults living in the UK who met diagnostic criteria for insomnia disorder and Patient Health Questionnaire-9 criteria (score ≥10) for depression were recruited online from the community and randomly assigned to either a 6-session digital CBT-I program or a sleep hygiene webpage. Participant recruitment took place between April 26, 2021, and January 24, 2022, and outcomes were assessed at 5 and 10 weeks post randomization. Data analysis was performed from December 1, 2022, to March 1, 2023.
Main outcomes and measures
Coprimary outcomes were recognition accuracy (percentage) of happy and sad facial expressions at 10 weeks assessed with the facial expression recognition task. Secondary outcomes were self-reported measures of insomnia, depressive symptoms, affect, emotional regulation difficulties, worry, perseverative thinking, midpoint of sleep, social jet lag, and the categorization of and recognition memory for emotional words. Intention-to-treat analysis was used.
Results
A total of 205 participants were randomly assigned to CBT-I (n = 101) or sleep hygiene education (n = 104). The sample had a mean (SD) age of 49.3 (10.1) years and was predominately female (165 [80.8%]). Retention was 85.7% (n = 175). At 10 weeks, the estimated adjusted mean difference for recognition accuracy was 3.01 (97.5% CI, -1.67 to 7.69; P = .15; Cohen d = 0.24) for happy facial expressions and -0.54 (97.5% CI, -3.92 to 2.84; P = .72; Cohen d = -0.05) for sad facial expressions. At 10 weeks, CBT-I compared with control decreased insomnia severity (adjusted difference, -4.27; 95% CI, -5.67 to -2.87), depressive symptoms (adjusted difference, -3.91; 95% CI, -5.20 to -2.62), negative affect (adjusted difference, -2.75; 95% CI, -4.58 to -0.92), emotional regulation difficulties (adjusted difference, -5.96; 95% CI, -10.61 to -1.31), worry (adjusted difference, -8.07; 95% CI, -11.81 to -4.33), and perseverative thinking (adjusted difference, -4.21; 95% CI, -7.03 to -1.39) and increased positive affect (adjusted difference, 4.99; 95% CI, 3.13-6.85). Improvement in negative affect, emotional regulation difficulties, and worry at week 5 mediated the effect of CBT-I on depression severity at 10 weeks (% mediated: 21.9% Emotion regulation difficulties; 24.4% Worry; and 29.7% Negative affect). No serious adverse events were reported to the trial team.
Conclusions and relevance
This randomized clinical trial did not find evidence that CBT-I engenders change in the perception of facial expressions at post treatment, despite improvements in insomnia and depressive symptoms. Early change in negative affect, emotional regulation difficulties, and worry mediated lagged depression outcomes and deserve further empirical scrutiny.
Trial registration
isrctn.org Identifier: ISRCTN17117237.
來源與署名
Emotional Processing Following Digital Cognitive Behavioral Therapy for Insomnia in People With Depressive Symptoms: A Randomized Clinical Trial.
Tamm S, Tse KYK, Hellier J, Saunders KEA, Harmer CJ, Espie CA, Reid M, Kyle SD.
JAMA network open · 2025-02-03
DOI: 10.1001/jamanetworkopen.2024.61502 ↗PubMed · 40014347 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
運動改善45歲及以上睡眠障礙者的睡眠質量評分
彙總23項隨機對照試驗、共1,478名45至77歲睡眠障礙成年人的資料,運動改善了匹茲堡睡眠質量指數評分(SMD 0.62,95%置信區間0.40–0.83),網路分析中有氧運動效果最大(SMD 1.34,95%可信區間0.86–1.82)。證據確定性為低到中等,結局是問卷評分,每週約539 MET-min的最佳劑量是模型估計值,不是處方。
Journal of Exercise Science & Fitness
睡眠規律性比睡眠時長更能預測英國成年人的死亡風險
在60,977名佩戴腕式加速度計一週的英國生物樣本庫成年人中,睡眠最規律的五分之一族群,經完全校正後的全因死亡風險比為0.70(95%置信區間0.59–0.83),對照為最不規律的五分之一,追蹤約6.3年,共1859人死亡。規律性對資料的擬合優於睡眠時長,但這是隻依據一週資料的觀察性研究。
Sleep
延長睡眠使超重成年人每日能量攝取減少約270千卡
在80名平時睡眠不足6.5小時的超重成年人中,兩週的延長睡眠指導使睡眠增加約1.2小時,實測能量攝取比對照組少270.4千卡/天(95%置信區間−393.4至−147.4)。這是一項為期短、單中心、族群較窄的試驗,不能說明體重會持續下降,也不能說明對睡眠本就充足的人有益。
JAMA Internal Medicine
50歲和60歲時每晚睡6小時及以下,與日後失智風險較高相關
在7959名英國公務員中追蹤約25年,50歲時每晚睡6小時及以下者的失智風險比為1.22(95%置信區間1.01–1.48),60歲時為1.37(1.10–1.72),均高於睡7小時者;長期持續睡眠偏短者為1.30(1.00–1.69)。睡眠主要靠自報,且為觀察性研究,早期腦部病變等因素可能解釋了部分關聯。
Nature Communications

